Search Result

Pathways Recommended:	Antibody-drug Conjugate/ADC Related

Results for "

Human Antibody

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Antibody (14) ADC Linker (1) Antibody-Drug Conjugates (ADCs) (10) Adenylate Cyclase (1) Akt (1) Amyloid-β (4) Anaplastic lymphoma kinase (ALK) (1) Angiotensin-converting Enzyme (ACE) (2) Antibiotic (1) AP-1 (2) Apoptosis (20) Autophagy (1) Bacterial (7) Biochemical Assay Reagents (1) c-Fms (7) c-Met/HGFR (4) Caspase (1) CCR (2) CD19 (1) CD20 (8) CD22 (3) CD276/B7-H3 (1) CD28 (2) CD3 (10) CD38 (4) CD6 (1) CD73 (1) CGRP Receptor (2) CMV (2) Complement System (8) CTLA-4 (8) CXCR (2) Drug-Linker Conjugates for ADC (6) EGFR (23) Endogenous Metabolite (2) Ephrin Receptor (1) ERK (1) Estrogen Receptor/ERR (1) Factor VIII (2) Factor Xa (4) FAP (1) FGFR (3) Filovirus (5) GCGR (3) GLP Receptor (1) Glucocorticoid Receptor (2) Glucosidase (1) Guanylate Cyclase (1) HBV (4) HCV (1) HIV (5) IFNAR (7) IGF-1R (8) Influenza Virus (5) Insulin Receptor (2) Integrin (8) Interleukin Related (65) Isotope-Labeled Compounds (2) Kallikrein (1) LAG-3 (6) LDLR (1) LPL Receptor (1) Macrophage migration inhibitory factor (MIF) (1) Mesothelin (1) Microtubule/Tubulin (5) MMP (1) Mucin (1) Nectin-4 (1) Neurotensin Receptor (1) NF-κB (2) Notch (5) Orexin Receptor (OX Receptor) (3) P-selectin (1) PARP (1) PCSK9 (6) PD-1/PD-L1 (32) PDGFR (3) RABV (4) RANKL/RANK (2) RSV (4) SARS-CoV (31) Ser/Thr Protease (1) STAT (1) STING (2) Survivin (1) TAM Receptor (2) Tau Protein (2) TGF-beta/Smad (4) TGF-β Receptor (9) Thrombin (1) Tie (1) TNF Receptor (35) Toll-like Receptor (TLR) (1) Topoisomerase (1) Transferrin Receptor (1) TSH Receptor (1) Tyrosinase (1) VEGFR (14) Wnt (2) α-synuclein (1)
By Research Areas:	Cancer (274) Cardiovascular Disease (28) Endocrinology (3) Infection (75) Inflammation/Immunology (518) Metabolic Disease (36) Neurological Disease (18)

By Targets:

ADC Antibody (14)

ADC Linker (1)

Antibody-Drug Conjugates (ADCs) (10)

Adenylate Cyclase (1)

Akt (1)

Amyloid-β (4)

Anaplastic lymphoma kinase (ALK) (1)

Angiotensin-converting Enzyme (ACE) (2)

Antibiotic (1)

AP-1 (2)

Apoptosis (20)

Autophagy (1)

Bacterial (7)

Biochemical Assay Reagents (1)

c-Fms (7)

c-Met/HGFR (4)

Caspase (1)

CCR (2)

CD19 (1)

CD20 (8)

CD22 (3)

CD276/B7-H3 (1)

CD28 (2)

CD3 (10)

CD38 (4)

CD6 (1)

CD73 (1)

CGRP Receptor (2)

CMV (2)

Complement System (8)

CTLA-4 (8)

CXCR (2)

Drug-Linker Conjugates for ADC (6)

EGFR (23)

Endogenous Metabolite (2)

Ephrin Receptor (1)

ERK (1)

Estrogen Receptor/ERR (1)

Factor VIII (2)

Factor Xa (4)

FAP (1)

FGFR (3)

Filovirus (5)

GCGR (3)

GLP Receptor (1)

Glucocorticoid Receptor (2)

Glucosidase (1)

Guanylate Cyclase (1)

HBV (4)

HCV (1)

HIV (5)

IFNAR (7)

IGF-1R (8)

Influenza Virus (5)

Insulin Receptor (2)

Integrin (8)

Interleukin Related (65)

Isotope-Labeled Compounds (2)

Kallikrein (1)

LAG-3 (6)

LDLR (1)

LPL Receptor (1)

Macrophage migration inhibitory factor (MIF) (1)

Mesothelin (1)

Microtubule/Tubulin (5)

MMP (1)

Mucin (1)

Nectin-4 (1)

Neurotensin Receptor (1)

NF-κB (2)

Notch (5)

Orexin Receptor (OX Receptor) (3)

P-selectin (1)

PARP (1)

PCSK9 (6)

PD-1/PD-L1 (32)

PDGFR (3)

RABV (4)

RANKL/RANK (2)

RSV (4)

SARS-CoV (31)

Ser/Thr Protease (1)

STAT (1)

STING (2)

Survivin (1)

TAM Receptor (2)

Tau Protein (2)

TGF-beta/Smad (4)

TGF-β Receptor (9)

Thrombin (1)

Tie (1)

TNF Receptor (35)

Toll-like Receptor (TLR) (1)

Topoisomerase (1)

Transferrin Receptor (1)

TSH Receptor (1)

Tyrosinase (1)

VEGFR (14)

Wnt (2)

α-synuclein (1)

By Research Areas:

Cancer (274)

Cardiovascular Disease (28)

Endocrinology (3)

Infection (75)

Inflammation/Immunology (518)

Metabolic Disease (36)

Neurological Disease (18)

440

Inhibitors & Agonists

Peptides

MCE Kits

913

Inhibitory Antibodies

Natural
Products

Isotope-Labeled Compounds

254

Antibodies

Sarilumab Anti-Human IL6Rα, Human Antibody	Interleukin Related	Inflammation/Immunology Cancer
Sarilumab (Anti-Human IL6Rα, Human Antibody) is a human immunoglobulin G1 monoclonal antibody. Sarilumab, a interleukin-6 (IL-6) receptor antagonist, binds to the IL-6 receptor with high affinity and inhibits cis and trans signaling by IL-6, resulting in reduced inflammation. Sarilumab can be used for the research of Rheumatoid arthritis .

Erenumab	CGRP Receptor	Others
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine .

Tisotumab Anti-Human F3 Recombinant Antibody	ADC Antibody	Cancer
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targets tissue factor (TF). Tisotumab can be used for the research of solid tumors .

Zalifrelimab AGEN1884	CTLA-4	Cancer
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling .

Adalimumab 5 Publications Verification Anti-Human TNF-alpha, Human Antibody	TNF Receptor Bacterial	Inflammation/Immunology Cancer
Adalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α).

Varlilumab CDX-1127	TNF Receptor	Cancer
Varlilumab (CDX-1127) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .

Bertilimumab CAT 213; iCo-008	CCR	Inflammation/Immunology
Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research .

Varlilumab (anti-CD27)	TNF Receptor	Cancer
Varlilumab (anti-CD27) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .

Onvatilimab JNJ-61610588	PD-1/PD-L1	Cancer
Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody. Onvatilimab has an anti-tumor activity .

Avelumab 5+ Cited Publications Anti-Human PD-L1, Human Antibody; MSB 0010718C; MSB0010718C	PD-1/PD-L1	Inflammation/Immunology Cancer
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.

Ustekinumab 1 Publications Verification Anti-Human IL-12/IL-23, Human Antibody	Interleukin Related	Inflammation/Immunology
Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody.

Inclacumab Anti-Human selectin P Recombinant Antibody	P-selectin	Cardiovascular Disease
Inclacumab (Anti-Human selectin P Recombinant Antibody) is a human monoclonal IgG4 antibody selectively targets P-selectin with a K_d value of 9.9 nM. Inclacumab inhibits P-selectin glycoprotein ligand 1 (PSGL-1) mimetic peptide bind with P-selectin with an IC₅₀ value of 1.9 μg/mL and strongly inhibits cell adhesion .

Aducanumab BIIB037	Amyloid-β	Neurological Disease
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research .

Daratumumab 1 Publications Verification Anti-Human CD38, Human Antibody	CD38 ADC Antibody	Inflammation/Immunology Cancer
Daratumumab (Anti-Human CD38) is the first-in-class human-specific *anti-CD38* monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .

Oleclumab MEDI9447	CD73	Cancer
Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .

Afasevikumab RG 7624; RO 5553110; NI-1401	Interleukin Related	Inflammation/Immunology
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities .

Patritumab 1 Publications Verification Human Anti-ERBB3 Recombinant Antibody	EGFR Akt ERK PARP Survivin	Cancer
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors .

Canakinumab Ilaris; ACZ 885	Interleukin Related	Inflammation/Immunology
Canakinumab (ACZ885) is a recombinant human *anti-IL-1β* monoclonal antibody. Canakinumab shows IC₅₀ values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin .

Daratumumab (PBS) 1 Publications Verification Anti-Human CD38, Human Antibody (PBS)	ADC Antibody CD38	Cancer
Daratumumab (PBS) (Anti-Human CD38) is the first-in-class human-specific *anti-CD38* monoclonal antibody (IgG1). Daratumumab (PBS) has anti-multiple myeloma (MM) effect. Daratumumab (PBS) impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .

Belimumab 2 Publications Verification LymphoStat B	TNF Receptor	Inflammation/Immunology
Belimumab (LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research .

Imalumab BAX69; Anti-Human MIF Recombinant Antibody	Macrophage migration inhibitory factor (MIF)	Cancer
Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer .

FG-3019 Pamrevlumab; Anti-Human CTGF Recombinant Antibody	Apoptosis	Cancer
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF). FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF) .

Namilumab AMG-203; Anti-Human CSF2 Recombinant Antibody	c-Fms	Inflammation/Immunology
Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis .

Xentuzumab 1 Publications Verification BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody	IGF-1R	Cancer
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation .

Panitumumab 1 Publications Verification ABX-EGF	EGFR	Cancer
Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer .

Timolumab BTT 1023; Anti-Human AOC3 Recombinant Antibody	AP-1	Inflammation/Immunology
Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases .

Tarextumab OMP 59R5; Anti-Human NOTCH2 Recombinant Antibody	Notch	Cancer
Tarextumab (OMP-59R5) is an anti-Notch2/3 fully human IgG2 monoclonal antibody. Tarextumab shows anti-tumor activity .

Sonepcizumab LT 1009; Anti-Human S1P Recombinant Antibody	LPL Receptor	Cancer
Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC) .

Panitumumab (anti-EGFR)	EGFR	Cancer
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer .

Abrilumab	Integrin	Infection Inflammation/Immunology Cancer
Abrilumab is a fully **human monoclonal antibody directed against α4β7**. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD) .

Raxibacumab ABthrax	Bacterial	Infection
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research .

Tesidolumab LFG316; Anti-Human C5 Recombinant Antibody	Complement System	Inflammation/Immunology
Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex .

Ulocuplumab BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody	CXCR	Cancer
Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models .

Drozitumab PRO 95780; rhuMAb-DR 5; Anti-Human DR5 Recombinant Antibody	Apoptosis	Cancer
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .

Tomuzotuximab Anti-Human EGFR Recombinant Antibody	EGFR Apoptosis	Cancer
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects .

Ganitumab AMG 479; Human Anti-IGF1R Recombinant Antibody	IGF-1R	Cancer
Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (K_D=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer .

Bermekimab MABp1	Interleukin Related	Inflammation/Immunology Cancer
Bermekimab (MABp1) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab prevents tumour-related inflammation .

Conatumumab AMG 655; TRAIL-R2 mAb; Human Anti-TNFRSF10B Recombinant Antibody	TNF Receptor	Cancer
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (K_d: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers. .

Eptinezumab	CGRP Receptor	Others
Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults .

Lumretuzumab Anti-Human ERBB3 Recombinant Antibody	EGFR	Cancer
Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody that can be used for the research of cancer .

Garadacimab 1 Publications Verification CSL312	Factor Xa	Cardiovascular Disease
Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research .

Anti-Human/Mouse denatured collagen type-I Antibody (XL313)	MMP	Others
Anti-Human/Mouse denatured collagen type-I Antibody (XL313) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to human/mouse denatured collagen type-I.

Tocilizumab 15+ Cited Publications Anti-Human IL6R, Humanized Antibody	Interleukin Related	Inflammation/Immunology Cancer
Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis . Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease) .

Seribantumab SAR 256212; MM 121; Anti-Human ERBB3/ErbB 3 Recombinant Antibody	EGFR Apoptosis	Cancer
Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3. Seribantumab blocks the activation of epidermal growth factor receptor (ErbB) family members and its downstream signal. Seribantumab inhibits neuregulin 1 (NRG1) fusion-dependent tumorigenesis in vitro and in vivo in breast, lung and ovarian patient-derived cancer models .

Vunakizumab Anti-Human IL17A Recombinant Antibody	Interleukin Related	Inflammation/Immunology
Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis .

Garetosmab REGN 2477	TGF-β Receptor	Inflammation/Immunology
Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research .

Cat. No.	Product Name	Target	Research Area

HY-P3203A

DSTYSLSSTLTLSK TFA	TNF Receptor	Inflammation/Immunology
DSTYSLSSTLTLSK TFA is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.

HY-P5276

Human membrane-bound PD-L1 polypeptide

PD-1/PD-L1 Cancer

Human membrane-bound PD-L1 polypeptide can be used as an antigen to induce PD-L1 antibody production .
HY-P4664

VHLTP

Peptides Inflammation/Immunology

VHLTP is the N-terminal pentapeptide of human hemoglobin beta. VHLTP binds to cell membranes and serves as a ligand for anti-HbA1c antibodies .

HY-P3203

DSTYSLSSTLTLSK	Peptides	Inflammation/Immunology
DSTYSLSSTLTLSK is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.

HY-108905

Mecasermin Human IGF-I; FK 780	IGF-1R	Metabolic Disease
Mecasermin (Human IGF-I; FK 780) is a recombinant human insulin-like growth factor I (IGF-I). Mecasermin has the potential for the study of the growth failure of growth hormone (GH) insensitivity caused by GH receptor defects or GH-inhibiting antibodies .

HY-P4025

ELDKWA	Peptides	Others
ELDKWA is the highly conserved amino acids on the ecto-domain of gp41. ELDKWA acts as the epitope of a neutralizing monoclonal antibody 2F5 (mAb 2F5) directed against human immunodeficiency virus type 1 .

HY-P10056

HEP-1 Human ezrin peptide (324-337)	HIV	Infection
HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV activity. HEP-1 enhances antibody titers generated by hepatitis B vaccination. HEP-1 has the potential to be studied against viral infections .

HY-P10109A

G6PI 325-339 (human) (hydrochloride) hG6PI (325-339) (hydrochloride)	Peptides	Inflammation/Immunology
G6PI 325-339 (human) hydrochloride is an efficient inducer of arthritis in B10.Q mice. G6PI 325-339 (human) hydrochloride primes Th1 and Th17 cells cross-reacted with the murine G6PI protein. G6PI 325-339 (human) hydrochloride induces arthritis model operating through a T and B cell-dependent pathway but without antibody effector mechanisms .

HY-P10109

G6PI 325-339 (human)	Peptides	Inflammation/Immunology
G6PI 325-339 (human) is an efficient inducer of arthritis in B10.Q mice. G6PI 325-339 (human) primes Th1 and Th17 cells cross-reacted with the murine G6PI protein. G6PI 325-339 (human) induces arthritis model operating through a T and B cell-dependent pathway but without antibody effector mechanisms .

HY-P5201S1

VTSEGAGLQLQK-13C6,15N2 TFA	Isotope-Labeled Compounds	Others
VTSEGAGLQLQK- ¹³C₆, ¹⁵N₂ (TFA) is the ¹³C- and ¹⁵N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .

HY-P3560

Edratide TV 4710	Apoptosis	Inflammation/Immunology
Edratide (TV 4710) is a synthetic peptide of 19 amino acid based on the complementarity-determining region 1 (CDR1) of a human anti-DNA antibody that expresses a major idiotype denoted 16/6 Id. Edratide reduces the rates of apoptosis (Apoptosis) and down-regulates of caspase-8 and caspase-3, up-regulates Bcl-xL. Edratide has the potential for the research of systemic lupus erythematosus (SLE) .

HY-P3385

Rilunermin alfa

SCB-313
Peptides Others

Rilunermin alfa (SCB-313) is an active compound. Rilunermin alfa can be used for various biochemical studies .

Cat. No.	Product Name

HY-K0213

Protein A Agarose 1 Publications Verification
MCE Protein A Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein A, effectively purifies mammalian monoclonal and polyclonal antibodies, such as human IgG, IgE, IgM.

HY-K0214

Protein G Agarose 2 Publications Verification
MCE Protein G Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein G, effectively purifies mammalian monoclonal and polyclonal antibodies, such as human IgG3 and rat IgG2a.

Cat. No.	Product Name	Target	Research Area

HY-P99278

Adecatumumab MT 201; Anti-Human EPCAM Recombinant Antibody	Inhibitory Antibodies	Cancer
Adecatumumab (Anti-Human EPCAM Recombinant Antibody; MT201) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status .

HY-P9916

Sarilumab Anti-Human IL6Rα, Human Antibody	Interleukin Related	Inflammation/Immunology Cancer
Sarilumab (Anti-Human IL6Rα, Human Antibody) is a human immunoglobulin G1 monoclonal antibody. Sarilumab, a interleukin-6 (IL-6) receptor antagonist, binds to the IL-6 receptor with high affinity and inhibits cis and trans signaling by IL-6, resulting in reduced inflammation. Sarilumab can be used for the research of Rheumatoid arthritis .

HY-P99242

Alsevalimab

Inhibitory Antibodies Cancer

Alsevalimab is a human monoclonal antibody against B7-H4 .

HY-P9938

Erenumab	CGRP Receptor	Others
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine .

HY-P990023

Bempikibart ADX-914	Inhibitory Antibodies	Inflammation/Immunology
Bempikibart (ADX-914) is a human anti-IL-7Rα antibody. Bempikibart can be used for the research of anti-inflammatory .

HY-P99271

Tisotumab Anti-Human F3 Recombinant Antibody	ADC Antibody	Cancer
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targets tissue factor (TF). Tisotumab can be used for the research of solid tumors .

HY-P99514

Zalifrelimab AGEN1884	CTLA-4	Cancer
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling .

HY-P9908

Adalimumab 5 Publications Verification Anti-Human TNF-alpha, Human Antibody	TNF Receptor Bacterial	Inflammation/Immunology Cancer
Adalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α).

HY-P99057

Varlilumab

CDX-1127
TNF Receptor Cancer

Varlilumab (CDX-1127) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .

HY-P99474

Bertilimumab CAT 213; iCo-008	CCR	Inflammation/Immunology
Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research .

HY-P99057A

Varlilumab (anti-CD27)

TNF Receptor Cancer

Varlilumab (anti-CD27) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .

HY-P99040

Onvatilimab JNJ-61610588	PD-1/PD-L1	Cancer
Onvatilimab (JNJ-61610588) is a human IgG1κ anti-VISTA (V-domain Ig Suppressor of T-cell Activation) monoclonal antibody. Onvatilimab has an anti-tumor activity .

HY-P99266

Zanolimumab Anti-Human CD4 Recombinant Antibody	Inhibitory Antibodies	Inflammation/Immunology Cancer
Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a fully human monoclonal antibody targets CD4. Zanolimumab effectively inhibits T-cell receptor (TCR) signal transduction. Zanolimumab can be used for the research of heumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma .

HY-108730

Avelumab 5+ Cited Publications Anti-Human PD-L1, Human Antibody; MSB 0010718C; MSB0010718C	PD-1/PD-L1	Inflammation/Immunology Cancer
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.

HY-P9909

Ustekinumab 1 Publications Verification Anti-Human IL-12/IL-23, Human Antibody	Interleukin Related	Inflammation/Immunology
Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody.

HY-P99263

Inclacumab Anti-Human selectin P Recombinant Antibody	P-selectin	Cardiovascular Disease
Inclacumab (Anti-Human selectin P Recombinant Antibody) is a human monoclonal IgG4 antibody selectively targets P-selectin with a K_d value of 9.9 nM. Inclacumab inhibits P-selectin glycoprotein ligand 1 (PSGL-1) mimetic peptide bind with P-selectin with an IC₅₀ value of 1.9 μg/mL and strongly inhibits cell adhesion .

HY-P9967

Aducanumab BIIB037	Amyloid-β	Neurological Disease
Aducanumab (BIIB037) is a human monoclonal antibody that selectively targets aggregated amyloid-beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research .

HY-P9915

Daratumumab 1 Publications Verification Anti-Human CD38, Human Antibody	CD38 ADC Antibody	Inflammation/Immunology Cancer
Daratumumab (Anti-Human CD38) is the first-in-class human-specific *anti-CD38* monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .

HY-P99460

Bapotulimab BAY-1905254	Inhibitory Antibodies	Inflammation/Immunology Cancer
Bapotulimab (BAY-1905254) is a fully human IgG2 antibody targeting immunoglobulin-like domain containing receptor 2 (ILDR2). Bapotulimab has antitumor and immunosuppressive effects .

HY-P99039

Oleclumab MEDI9447	CD73	Cancer
Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .

HY-P99424

Afasevikumab RG 7624; RO 5553110; NI-1401	Interleukin Related	Inflammation/Immunology
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities .

HY-P99179

CTX-2026	Inhibitory Antibodies	Cancer
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer .

HY-P99275

Patritumab 1 Publications Verification Human Anti-ERBB3 Recombinant Antibody	EGFR Akt ERK PARP Survivin	Cancer
Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors .

HY-108810

Canakinumab Ilaris; ACZ 885	Interleukin Related	Inflammation/Immunology
Canakinumab (ACZ885) is a recombinant human *anti-IL-1β* monoclonal antibody. Canakinumab shows IC₅₀ values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin .

HY-P9915A

Daratumumab (PBS) 1 Publications Verification Anti-Human CD38, Human Antibody (PBS)	ADC Antibody CD38	Cancer
Daratumumab (PBS) (Anti-Human CD38) is the first-in-class human-specific *anti-CD38* monoclonal antibody (IgG1). Daratumumab (PBS) has anti-multiple myeloma (MM) effect. Daratumumab (PBS) impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .

HY-P9952

Belimumab 2 Publications Verification LymphoStat B	TNF Receptor	Inflammation/Immunology
Belimumab (LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab can be used for systemic lupus erythematosus (SLE) research .

HY-P99262

Imalumab BAX69; Anti-Human MIF Recombinant Antibody	Macrophage migration inhibitory factor (MIF)	Cancer
Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer .

HY-P99288

FG-3019 Pamrevlumab; Anti-Human CTGF Recombinant Antibody	Apoptosis	Cancer
FG-3019 (Pamrevlumab) is a recombinant human antibody that binds to connective tissue growth factor (CTGF). FG-3019 can be used for the research of idiopathic pulmonary fibrosis (IPF) .

HY-P99307

Namilumab AMG-203; Anti-Human CSF2 Recombinant Antibody	c-Fms	Inflammation/Immunology
Namilumab (AMG203) is a human IgG1 monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. Namilumab can be used for the research of rheumatoid arthritis .

HY-P99274

Xentuzumab 1 Publications Verification BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody	IGF-1R	Cancer
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation .

HY-P99041

Panitumumab 1 Publications Verification ABX-EGF	EGFR	Cancer
Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer .

HY-P99323

Timolumab BTT 1023; Anti-Human AOC3 Recombinant Antibody	AP-1	Inflammation/Immunology
Timolumab (BTT1023 ), a recombinant fully human monoclonal antibody that specifically binds VAP-1. Timolumab (BTT1023 ) could be used in the study of chronic inflammatory diseases .

HY-P99320

Tarextumab OMP 59R5; Anti-Human NOTCH2 Recombinant Antibody	Notch	Cancer
Tarextumab (OMP-59R5) is an anti-Notch2/3 fully human IgG2 monoclonal antibody. Tarextumab shows anti-tumor activity .

HY-P99318

Sonepcizumab LT 1009; Anti-Human S1P Recombinant Antibody	LPL Receptor	Cancer
Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC) .

HY-P99041A

Panitumumab (anti-EGFR)	EGFR	Cancer
Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer .

HY-P99184

Abrilumab	Integrin	Infection Inflammation/Immunology Cancer
Abrilumab is a fully **human monoclonal antibody directed against α4β7**. Abrilumab selectively binds the α4β7 integrin heterodimer. Abrilumab can be used for the research of inflammatory bowel disease (IBD) .

HY-P9957

Raxibacumab ABthrax	Bacterial	Infection
Raxibacumab (ABthrax) is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen (PA). Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research .

HY-P99257

Bleselumab ASKP 1240; Anti-Human CD40 Recombinant Antibody	Inhibitory Antibodies	Inflammation/Immunology
Bleselumab (ASKP 1240) is a human anti-CD40 monoclonal antibody (mAb). Bleselumab binds to human CD40 with high affinity (K_d: 0.24 nM). Bleselumab inhibits immune responses by blocking the interaction of CD40 with its ligand CD40L. Bleselumab prevents organ transplant rejection .

HY-P99322

Tesidolumab LFG316; Anti-Human C5 Recombinant Antibody	Complement System	Inflammation/Immunology
Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex .

HY-P99272

Ulocuplumab BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody	CXCR	Cancer
Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models .

HY-P99265

Mapatumumab HGS-ETR1; Anti-Human TNFRSF10A Recombinant Antibody	Inhibitory Antibodies	Cancer
Mapatumumab (HGS-ETR1) is a fully human IgG1 agonistic monoclonal antibody that targets tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1). Mapatumumab can be used for the research of cancer .

HY-P99286

Drozitumab PRO 95780; rhuMAb-DR 5; Anti-Human DR5 Recombinant Antibody	Apoptosis	Cancer
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma .

HY-P99324

Tomuzotuximab Anti-Human EGFR Recombinant Antibody	EGFR Apoptosis	Cancer
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects .

HY-P99294

Ganitumab AMG 479; Human Anti-IGF1R Recombinant Antibody	IGF-1R	Cancer
Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human type 1 insulin-like growth factor receptor (IGF1R). Ganitumab recognizes murine IGF1R with sub-nanomolar affinity (K_D=0.22 nM) and inhibits the interaction of murine IGF1R with IGF1 and IGF2. Ganitumab can be used in research of cancer .

HY-P99246

Bermekimab MABp1	Interleukin Related	Inflammation/Immunology Cancer
Bermekimab (MABp1) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab prevents tumour-related inflammation .

HY-P99260

Conatumumab AMG 655; TRAIL-R2 mAb; Human Anti-TNFRSF10B Recombinant Antibody	TNF Receptor	Cancer
Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (K_d: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers. .

HY-111965

PF-06647263

anti-EFNA4-ADC
Inhibitory Antibodies Inflammation/Immunology
HY-P990316

AGS-1C4D4

Inhibitory Antibodies Inflammation/Immunology
HY-P990317

AGS-67E

Inhibitory Antibodies Inflammation/Immunology
HY-P990321

AMG-108

Inhibitory Antibodies Inflammation/Immunology

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80276

	Phospho-AKT1(Ser473) Antibody AKT 1 Antibody; AKT Antibody; AKT1 Antibody; AKT1_Human Antibody; MGC99656 Antibody; PKB Antibody; PKB-ALPHA Antibody; PRKBA Antibody; Protein Kinase B Alpha Antibody; Protein kinase B Antibody; Proto-oncogene c-Akt Antibody; RAC Alpha Antibody; RAC Antibody; RAC-alpha serine/threonine-protein kinase Antibody; RAC-PK-alpha Antibody;	WB, ICC/IF, IHC-P	Human, Mouse
	Phospho-Akt1(Ser473) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to Phospho-Akt1(Ser473). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

HY-P80464

	Phospho-Hormone sensitive lipase (Ser853) Antibody Hormone sensitive lipase Antibody; Hormone sensitive lipase testicular isoform Antibody; Hormone-sensitive lipase Antibody; HSL Antibody; LHS; Lipase hormone sensitive Antibody; LIPE Antibody; LIPS_Human Antibody; Phospho-Hormonesensitivelipase(S853); PhosphoHormonesensitivelipase(S853)	WB, IHC-P	Human, Mouse, Rat
	Phospho-Hormone sensitive lipase (Ser853) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 117 kDa, targeting to Phospho-Hormone sensitive lipase (S853). It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

HY-P83658

	CTSE Antibody CATE Antibody; CATE_Human Antibody; Cathepsin E Antibody; Cathepsin E form II Antibody; CTSE Antibody; Erythrocyte membrane aspartic proteinase Antibody; Slow moving proteinase Antibody;	WB, IHC-P	Human, Mouse, Rat
	CTSE Antibody is a rabbit-derived non-conjugated IgG antibody, targeting CTSE, with a predicted molecular weight of 43 kDa (observed band size: 48 kDa). CTSE Antibody can be used for WB, IHC-P experiments in human, mouse, rat backgrounds.

HY-P83669

	delta Tubulin Antibody TUBD1,TUBD,FLJ12709,TBD_Human Antibody,Tubulin delta chain antibod	WB, IHC-P	Human, Mouse
	deltaTubulin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 51 kDa, targeting to delta Tubulin. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

HY-P81048

	Collagen VI Antibody (YA893) Alpha 1 (VI) chain (61 AA) Antibody; CO6A1_Human Antibody; COL6A1 Antibody; Collagen alpha-1(VI) chain Antibody; Collagen type VI alpha 1 Antibody; Collagen VI alpha 1 polypeptide Antibody; Collagen VI Antibody; Human mRNA for collagen VI alpha 2 C terminal globular domain Antibody; OPLL Antibody; PP3610 Antibody	WB, ICC/IF, IHC-P	Human, Mouse, Rat
	Collagen VI Antibody (YA893) is an unconjugated, approximately 109 kDa, rabbit-derived, anti-Collagen VI (YA893) monoclonal antibody. Collagen VI Antibody (YA893) can be used for: WB, IF-Cell, IF-Tissue, IHC-P expriments in human, mouse, rat background without labeling.

HY-P83202

	HspA12A Antibody (YA2947) FLJ13874 Antibody; Heat shock 70 kDa protein 12A Antibody; heat shock 70kD protein 12A Antibody; heat shock 70kDa protein 12A Antibody; HS12A_Human Antibody; Hspa12a Antibody; KIAA0417 Antibody	WB, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	HspA12A Antibody (YA2947) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2947), targeting HspA12A, with a predicted molecular weight of 75 kDa (observed band size: 75 kDa). HspA12A Antibody (YA2947) can be used for WB, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.

HY-P81317

	Human IgM Antibody (YA1062) Ig mu chain C region	ELISA, IHC-P	Human
	Human IgM Antibody (YA1062) is a mouse-derived non-conjugated IgG2a antibody (Clone NO.: YA1062), targeting Human IgM. Human IgM Antibody (YA1062) can be used for ELISA, IHC-P experiment in human background.

HY-P81249

	NALP12/NLRP12 Antibody CLR19.3 Antibody; FCAS2 Antibody; Monarch 1 Antibody; Monarch-1 Antibody; NACHT, leucine rich repeat and PYD containing 12 Antibody; NACHT, LRR and PYD containing protein 12 Antibody; NACHT, LRR and PYD domains-containing protein 12 Antibody; NAL12_Human Antibody; NLR family, pyrin domain containing 12 Antibody; NLRP12 Antibody; Nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 12 Antibody; OTTHUMP00000067227 Antibody; PAN6 Antibody; PYPAF7 Antibody; PYRIN containing APAF1 like protein 7 Antibody; PYRIN-containing APAF1-like protein 7 Antibody; Regulated by nitric oxide Antibody; RNO Antibody; RNO2 Antibody;	ELISA, IHC-P, IHC-F, ICC/IF	Human, Rat, Mouse, Dog, Pig, Cow, Horse, Rabbit, Sheep
	NALP12/NLRP12 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting NALP12/NLRP12, with a predicted molecular weight of 117 kDa (observed band size: ). NALP12/NLRP12 Antibody can be used for ELISA, IHC-P, IHC-F, ICC/IF experiments in human, rat, mouse, dog, pig, cow, horse, rabbit, sheep backgrounds.

HY-P80347

	STAT6 Antibody 12S1644 Antibody; D12S1644 Antibody; IL 4 STAT Antibody; IL-4 Stat Antibody; IL4 STAT Antibody; Interleukin 4 Induced Antibody; Interleukin 4 Induced Transcription Factor IL4 STAT Antibody; Signal transducer and activator of transcription 6 Antibody; Signal Transducer And Activator Of Transcription 6 Interleukin 4 Induced Antibody; Signal Transducer And Activator Of Transcription 6 Nirs Variant 1 Antibody; Signal transducer and activator of transcription 6, interleukin 4 induced Antibody; STAT 6 Antibody; STAT interleukin4 induced Antibody; STAT, interleukin4 induced Antibody; Stat6 Antibody; STAT6_Human Antibody; STAT6B Antibody; STAT6C Antibody; Transcription factor IL 4 STAT Antibody;	WB, ICC/IF, IHC-P, IP	Human, Mouse
	STAT6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 94 kDa, targeting to STAT6. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Mouse.

HY-P81253

	Myoglobin Antibody (YA925) MYO; MB; MGC13548; PVALB; MYG_Human.	WB, IHC-P, IHC-F, ICC/IF, ELISA	Human, Mouse, Rat
	Myoglobin Antibody (YA925) is a mouse-derived non-conjugated IgG antibody (Clone NO.: YA925), targeting Myoglobin, with a predicted molecular weight of 17 kDa (observed band size: ). Myoglobin Antibody (YA925) can be used for WB, IHC-P, IHC-F, ICC/IF, ELISA experiment in human, mouse, rat background.

HY-P80955

	beta Tubulin Antibody (YA839) Human,Mouse,Monkey,Goat,Hamster,Rat,ChlamydomonasReinhardtii	WB, ICC/IF	Human, Mouse, Monkey, Goat, Hamster, Rat, Chlamydomonas Reinhardtii
	beta Tubulin Antibody (YA839) is a non-conjugated and Mouse origined monoclonal antibody about 50-55 kDa, targeting to Tubulin beta chain (TUBB). It can be used for WB,ICC/IF assays in the background of Human, Mouse, Monkey, Goat, Hamster, Rat, Chlamydomonas Reinhardtii.

HY-P81784

	Endo G Antibody (YA1529) EndoG; EndonucleaseG; Mitochondrial endonuclease G; NUCG_Human	WB	Human, Mouse, Rat
	Endo G Antibody (YA1529) is a biotin-conjugated non-conjugated IgG antibody, targeting Endo G, with a predicted molecular weight of 33 kDa (observed band size: 30 kDa). Endo G Antibody (YA1529) can be used for WB experiment in human, mouse, rat background.

HY-P82627

	SMURF2 Antibody (YA2372) hSMURF2; SMUF2_Human; Smurf2	WB	Human, Mouse, Rat
	SMURF2 Antibody (YA2372) is a biotin-conjugated non-conjugated IgG antibody, targeting SMURF2, with a predicted molecular weight of 86 kDa (observed band size: 86 kDa). SMURF2 Antibody (YA2372) can be used for WB experiment in human, mouse, rat background.

HY-P83102

	Follistatin Antibody (YA2847) Activin binding protein; Follistatin; FS; fst; Human follistatin gene	WB	Rat
	Follistatin Antibody (YA2847) is a biotin-conjugated non-conjugated IgG antibody, targeting Follistatin, with a predicted molecular weight of 38 kDa (observed band size: 38 kDa). Follistatin Antibody (YA2847) can be used for WB experiment in rat background.

HY-P81152

	EPOR Antibody erythropoietin receptor; EPO R; EPO Receptor; Erythropoietin receptor precursor; EPOR_Human; MGC138358.	WB, ELISA, IHC-P, IHC-F, ICC/IF	Human, Rat
	EPOR Antibody is an unconjugated, approximately 56 kDa, rabbit-derived, anti-EPOR polyclonal antibody. EPOR Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse, dog, cow, horse background without labeling.

HY-P81194

	EPX Antibody Eosinophil peroxidase; Eosinophil peroxidase heavy chain; EPER; EPO; EPP; EPX PEN; PERE; PERE_Human.	ELISA, IHC-P, IHC-F, ICC/IF	Human, Mouse
	EPX Antibody is an unconjugated, approximately 79 kDa, rabbit-derived, anti-EPX polyclonal antibody. EPX Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.

HY-P83076

	LRRK2 Antibody (YA2821) AURA17; Dardarin Antibody; ; Leucine rich repeat kinase 2; LRRK 2 Antibody; LRRK2; LRRK2_Human; PARK 8; PARK8; RIPK7; ROCO 2; ROCO2	WB, IHC-P, ICC/IF	Human, Mouse
	LRRK2 Antibody (YA2821) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2821), targeting LRRK2, with a predicted molecular weight of 286 kDa (observed band size: 286 kDa). LRRK2 Antibody (YA2821) can be used for WB, IHC-P, ICC/IF experiment in human, mouse background.

HY-P81155

	OCLN Antibody OCLN_Human; Occludin; Ocl; BLCPMG; PPP1R115; PTORCH1; Tight junction protein occludin	WB, ELISA, FC	Human
	OCLN Antibody is an unconjugated, approximately 57 kDa, rabbit-derived, anti-OCLN polyclonal antibody. OCLN Antibody can be used for: WB, ELISA, Flow-Cyt expriments in human, and predicted: mouse, rat, dog, pig, cow, horse, guinea pig background without labeling.

HY-P83582

	Human IgG4 Antibody (YA3327) IGG4; Ig gamma 4 chain C region	WB, IHC-P	Human
	Human IgG4 Antibody (YA3327) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3327), targeting Human IgG4, with a predicted molecular weight of 36 kDa (observed band size: 36 kDa). Human IgG4 Antibody (YA3327) can be used for WB, IHC-P experiment in human background.

HY-P81237

	Wnt10a Antibody FLJ14301; OODD; Protein Wnt-10a ; SSPS; STHAG4; Wingless type MMTV integration site family member 10A Antibody; WN10A_Human; wnt10a;	WB, ICC/IF, IHC-P	Human, Mouse
	Wnt10a Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Wnt10a, with a predicted molecular weight of 46 kDa (observed band size: ). Wnt10a Antibody can be used for WB, ICC/IF, IHC-P experiments in human, mouse backgrounds.

HY-P81116

	IRS1 Antibody IRS1_Human; Insulin receptor substrate 1; IRS-1; IRS 1	WB, ELISA, IHC-P, IHC-F, ICC/IF	Human, Mouse, Rat, Pig
	IRS1 Antibody is an unconjugated, approximately 137 kDa, rabbit-derived, anti-IRS1 polyclonal antibody. IRS1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, pig, and predicted: chicken background without labeling.

HY-P82251

	Human kappa Light Chain Antibody (YA1996) HCAK1; Ig kappa chain C region; IGKC; IMMUNOGLOBULIN InV; Km	WB, IHC-P, ICC/IF	Human
	Human kappa Light Chain Antibody (YA1996) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1996), targeting Human kappa Light Chain, with a predicted molecular weight of 12 kDa (observed band size: 26 kDa). Human kappa Light Chain Antibody (YA1996) can be used for WB, IHC-P, ICC/IF experiment in human background.

HY-P82589

	Claudin 11 Antibody (YA2334) Claudin 11; CLD11_Human; Cldn11; OSP; OTM	WB, FC	Human, Mouse, Rat
	Claudin 11 Antibody (YA2334) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2334), targeting Claudin 11, with a predicted molecular weight of 22 kDa (observed band size: 22 kDa). Claudin 11 Antibody (YA2334) can be used for WB, FC experiment in human, mouse, rat background.

HY-P80076

	Cdk2 Antibody Cdc2 related protein kinase; CDC28; CDC2A; Cdk 2; CDK1; CDK2; CDK2_Human ; CDKN2; MPF; p33(CDK2) Antibody	WB, ICC/IF, IHC-P, IP, FC	Human, Mouse, Rat
	Cdk2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to Cdk2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse,Rat.

HY-P81104

	Calcitonin receptor Antibody Calcitonin receptor precursor; Calcr; CRT; CT R; CTR; CTR1; CALCR_MOUSE; CT-R; CALCR_Human.	ELISA, IHC-P, IHC-F, ICC/IF	Rat
	Calcitonin receptor Antibody is an unconjugated, approximately 53 kDa, rabbit-derived, anti-Calcitonin receptor polyclonal antibody. Calcitonin receptor Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in rat, and predicted: mouse background without labeling.

HY-P81107

	Growth hormone receptor Antibody GH receptor; GHBP; GHR; Growth hormone receptor precursor; Serum binding protein; Somatotropin receptor; GHR_Human.	WB	Human, Mouse, Rat
	Growth hormone receptor Antibody is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Growth hormone receptor polyclonal antibody. Growth hormone receptor Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow, sheep background without labeling.

HY-P81109

	LDLR Antibody LDLR_Human; Low-density lipoprotein receptor; LDL receptor; FH; FHC; FHCL1; LDLCQ2; low density lipoprotein receptor	WB, ELISA, FC, ICC/IF	Human, Mouse
	LDLR Antibody is an unconjugated, approximately 92 kDa, rabbit-derived, anti-LDLR polyclonal antibody. LDLR Antibody can be used for: WB, ELISA, Flow-Cyt, ICC expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit, guinea pig background without labeling.

HY-P81219

	MPO Antibody Myeloperoxidase; MPO; 89 kDa myeloperoxidase; 84 kDa yeloperoxidase; Myeloperoxidase heavy chain; EC 1.11.1.7; PERM_Human.	ELISA, IHC-P, IHC-F, ICC/IF	Human, Mouse
	MPO Antibody is an unconjugated, approximately 84 kDa, rabbit-derived, anti-MPO polyclonal antibody. MPO Antibody can be used for: ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, and predicted: rat, dog, horse, rabbit, guinea pig background without labeling.

HY-P81125

	SP7/Osterix Antibody SP7_Human; Transcription factor Sp7; OSX; Zinc finger protein osterix; Sp7 transcription factor; Osterix	WB, ELISA	Human, Mouse
	SP7/Osterix Antibody is an unconjugated, approximately 45 kDa, rabbit-derived, anti-SP7/Osterix polyclonal antibody. SP7/Osterix Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, horse, rabbit background without labeling.

HY-P81145

	Oxytocin R Antibody OXYR_Human; Oxytocin receptor; OXTR; OTR1; OT-R; OTR; OT R; OTR 1; OXT R	WB, ELISA, IHC-P	Human, Mouse, Rat
	Oxytocin R Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-Oxytocin R polyclonal antibody. Oxytocin R Antibody can be used for: WB, ELISA, IHC-P expriments in human, mouse, rat, and predicted: dog, pig, cow, horse background without labeling.

HY-P82048

	ERp29 Antibody (YA1793) ERp28; ERP29_Human; ERp31; HEL S 107; PDI-DB; PDIA9	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	ERp29 Antibody (YA1793) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1793), targeting ERp29, with a predicted molecular weight of 29 kDa (observed band size: 29 kDa). ERp29 Antibody (YA1793) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.

HY-P81136

	Aquaporin 5 Antibody Aquaporin 5; AQP5; AQP 5; AQP-5; AQP5_Human; Aquaporin-5.	WB, ELISA, IHC-P, IHC-F, FC, ICC/IF	Human, Mouse, Rat
	Aquaporin 5 Antibody is an unconjugated, approximately 29 kDa, rabbit-derived, anti-Aquaporin 5 polyclonal antibody. Aquaporin 5 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, sheep background without labeling.

HY-P81795

	Insulin Receptor Antibody (YA1540) CD220; HHF5; Human insulin receptor; Insr; Insulin receptor subunit beta; IR 1; IR	WB, ICC/IF	Human, Rat
	Insulin Receptor Antibody (YA1540) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1540), targeting Insulin Receptor, with a predicted molecular weight of 156 kDa (observed band size: 95 kDa). Insulin Receptor Antibody (YA1540) can be used for WB, ICC/IF experiment in human, rat background.

HY-P83072A

	FDPS Antibody FPPS_Human; Farnesyl pyrophosphate synthase; FPP synthase; FPS; (2E,6E)-farnesyl diphosphate synthase; Dimethylallyltranstransferase; Farnesyl diphosphate synthase; Geranyltranstransferase.	IHC-P, IHC-F, ICC/IF, ELISA	Rat, Mouse
	FDPS Antibody is a rabbit-derived non-conjugated antibody, targeting FDPS, with a predicted molecular weight of 48 kDa (observed band size: ). FDPS Antibody can be used for IHC-P, IHC-F, ICC/IF, ELISA experiments in rat, mouse backgrounds.

HY-P81219A

	MPO Antibody(YA3392) Myeloperoxidase; MPO; 89 kDa myeloperoxidase; 84 kDa yeloperoxidase; Myeloperoxidase heavy chain; EC 1.11.1.7; PERM_Human.	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	MPO Antibody is an unconjugated, approximately 84 kDa, mouse-derived, anti-MPO monoclonal antibody. MPO Antibody can be used for: WB, IHC-P, IF-Cell, IF-Tissue expriments in human, mouse, rat background without labeling.

HY-P82451

	Human IgG2 Antibody (YA2196) IGHG2; immunoglobulin Gm2; immunoglobulin heavy constant gamma 2 (G2m marker)	WB, IHC-P, ICC/IF	Human
	Human IgG2 Antibody (YA2196) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2196), targeting Human IgG2, with a predicted molecular weight of 36 kDa (observed band size: 53 kDa). Human IgG2 Antibody (YA2196) can be used for WB, IHC-P, ICC/IF experiment in human background.

HY-P81092

	DRD2 Antibody DRD2_Human; D(2) dopamine receptor; Dopamine D2 receptor; dopamine receptor D2; D2R; D2DR	WB, ELISA, IHC-P, IHC-F, ICC/IF	Rat
	DRD2 Antibody is an unconjugated, approximately 51 kDa, rabbit-derived, anti-DRD2 polyclonal antibody. DRD2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: human, mouse background without labeling.

HY-P81093

	BMP2 Antibody Bone morphogenetic protein 2; BMP 2; BMP 2A; BMP2A; BMP-2; BMP2_Human.	WB, ELISA, IHC-P, IHC-F, ICC/IF	Human, Mouse, Rat
	BMP2 Antibody is an unconjugated, approximately 13/44 kDa, rabbit-derived, anti-BMP2 polyclonal antibody. BMP2 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: chicken, dog, cow, horse, rabbit, sheep background without labeling.

HY-P83647

	DHCR7 Antibody 7 dehydrocholesterol reductase; 7 DHC reductase; Delta 7 dehydrocholesterol reductase; Putative sterol reductase SR 2; Sterol Delta; DHCR7_Human.	WB, ELISA	Human, Mouse, Rat
	DHCR7 Antibody is a rabbit-derived non-conjugated IgG antibody, targeting DHCR7, with a predicted molecular weight of 54 kDa (observed band size: 54 kDa). DHCR7 Antibody can be used for WB, ELISA experiments in human, mouse, rat backgrounds.

HY-P81098

	CD34 Antibody CD34 antigen; CD34 molecule; Cluster designation 34; Hematopoietic progenitor cell antigen CD34; HPCA1; CD34_Human.	WB, ELISA, IHC-P, IHC-F, FC, ICC/IF	Human, Mouse
	CD34 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-CD34 polyclonal antibody. CD34 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit background without labeling.

HY-P83666M

Human CD235 Antibody-APC

Glycophorin-A/B; GYPA/B; MN sialoglycoprotein; SS-active sialoglycoprotein; PAS-2/3; Sialoglycoprotein alpha/delta; CD235a/b
FC Human

HY-P81241

	Leptin Antibody LEP; Leptin Murine Obesity Homolog; Leptin Precursor Obesity Factor; OB; Obese Protein; Obesity; Obesity factor; Obesity homolog mouse; Obesity Murine Homolog Leptin; OBS; LEP_Human.	IHC-P, IHC-F, ICC/IF, ELISA	Human, Mouse, Rat, Pig, Sheep
	Leptin Antibody is a rabbit-derived non-conjugated IgG antibody, targeting Leptin, with a predicted molecular weight of 16 kDa (observed band size: ). Leptin Antibody can be used for IHC-P, IHC-F, ICC/IF, ELISA experiments in human, mouse, rat, pig, sheep backgrounds.

HY-P81222

	CLDN1 Antibody CLD1_Human; Claudin-1; Claudin 1; Claudin1; CLD1; SEMP1; Senescence-associated epithelial membrane protein; UNQ481/PRO944; ILVASC	WB, ELISA, IHC-P, IHC-F, ICC/IF	Human, Mouse
	CLDN1 Antibody is an unconjugated, approximately 23 kDa, rabbit-derived, anti-CLDN1 polyclonal antibody. CLDN1 Antibody can be used for: WB, ELISA, IHC-, IHC-, IF expriments in human, mouse, and predicted: rat, pig, cow, horse, rabbit, sheep, guinea pig background without labeling.

HY-P83656

	IL-23R Antibody Interleukin-23 receptor; IL23 Receptor; IL23R; IL 23R; interleukin 23 receptor; IL-23 receptor; IL23R_Human.	WB, IHC-P	Human
	IL-23R Antibody is a biotin-conjugated non-conjugated IgG antibody, targeting IL-23R, with a predicted molecular weight of 72 kDa (observed band size: 72 kDa). IL-23R Antibody can be used for WB, IHC-P experiment in human background.

HY-P80378

	AHR Antibody Ah receptor; Aromatic hydrocarbon receptor; Aryl hydrocarbon receptor; Aryl hydrocarbon receptor precursor; BHLHE76; Class E basic helix loop helix protein 76; HGNC:348; AHR_Human.	WB, ICC/IF	Human
	Aryl hydrocarbon Receptor Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 96 kDa, targeting to Aryl hydrocarbon Receptor. It can be used for WB,ICC/IF assays with tag free, in the background of Human.

HY-P81231

	Occludin Antibody Occludin, Occludin-1; Occludin1; Occludin 1; FLJ08163; BLCPMG; FLJ18079; FLJ77961; FLJ94056; MGC34277; Occludin; OCLN; OCLN_Human; Tight junction protein occludin.	WB, ICC/IF, IHC-P, FC	Human, Mouse, Rat
	Occludin Antibody is an unconjugated, approximately 59 kDa, rabbit-derived, anti-Occludin polyclonal antibody. Occludin Antibody can be used for: 0 expriments in human, mouse, rat, and predicted: dog, pig, cow, sheep background without labeling.

HY-P81215

	Neutrophil Elastase Antibody Bone Marrow Serine Protease; ELA 2; ELA2; ELANE; Elastase 2; Elastase-2; Elastase 2 neutrophil; Elastase neutrophil expressed; Elastase-2; ELNE_Human; GE Antibody Granulocyte derived elastase; HLE; HNE; Human leukocyte elastase; Leukocyte elastase; Leukocyte Elastase Precursor; Medullasin; NE; Neutrophil elastase; Neutrophill elastase; PMN E; PMN Elastase; Polymorphonuclear elastase; SCN1; Serine protease; SERP1.	WB, ELISA, FC,	Human, Mouse, Rat
	Neutrophil Elastase Antibody is an unconjugated, approximately 26 kDa, rabbit-derived, anti-Neutrophil Elastase polyclonal antibody. Neutrophil Elastase Antibody can be used for: WB, ELISA, Flow-Cyt, expriments in human, mouse, rat, and predicted: dog background without labeling.

HY-P80008

	AKT1 Antibody (YA634) AKT 1; AKT; AKT1; AKT1_Human ; MGC99656; PKB; PKB-ALPHA; PRKBA; Protein Kinase B Alpha ; Proto-oncogene c-Akt; RAC Alpha;	IHC-P, IHC-F, ICC/IF, IP, FC	Human, Mouse
	AKT1 Antibody (YA634) is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT1. It can be used for WB,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse.

HY-P81281

	Human Serum Albumin Antibody (YA984) ALB; ALBU_Human; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; Serum albumin.	ELISA	Human
	Human Serum Albumin Antibody (YA984) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA984), targeting Human Serum Albumin. Human Serum Albumin Antibody (YA984) can be used for ELISA experiment in human background.

HY-P81281A

	Human Serum Albumin Antibody (YA985) ALB; ALBU_Human; Albumin (32 AA); Albumin (AA 34); Albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; Serum albumin.	WB, ELISA	Human
	Human Serum Albumin Antibody (YA985) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA985), targeting Human Serum Albumin, with a predicted molecular weight of 69 kDa (observed band size: 69 kDa). Human Serum Albumin Antibody (YA985) can be used for WB, ELISA experiment in human background.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks